Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286624 · ClinicalTrials.gov registry record · Phase 1
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00286624: Completed Phase 1 study, sponsored by University of Minnesota.
NCT00286624 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00286624, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study was designed to test the safety and efficacy of up to 3 pancreatic alloislet transplants in type 1 diabetic patients with hypoglycemia unawareness. 6 subjects were transplanted under this protocol using anti-thymocyte globulin induction immunosuppression and everolimus with cyclosporine maintenance immunosuppression.
Interventions
- DRUG Everolimus
- DRUG Cyclosporine
- DRUG anti-thymocyte globulin
- BIOLOGICAL Allogeneic Islets of Langerhans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2003-03 |
| Est. Completion | 2006-08 |
| Phase | Phase 1 |
What the finished NCT00286624 record still lists
NCT00286624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 4 interventions - of which Everolimus is the first listed.
NCT00286624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00286624 about?
NCT00286624 is a clinical study titled "Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation". This study was designed to test the safety and efficacy of up to 3 pancreatic alloislet transplants in type 1 diabetic patients with hypoglycemia unawareness. 6 subjects were transplanted under this protocol using anti-thymocyte globulin induction immunosuppression and everolimus with cyclosporine m...
What is the current status of trial NCT00286624?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2003-03. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00286624?
The interventions under investigation include: Everolimus (DRUG), Cyclosporine (DRUG), anti-thymocyte globulin (DRUG), Allogeneic Islets of Langerhans (BIOLOGICAL).
Who is sponsoring clinical trial NCT00286624?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00286624's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia